

November has been a busy month in the world of rejuvenation biotechnology and life extension, as there has been both really good news and some rather bad news. Let’s have

With the recent increase of enthusiastic support for the idea of defeating aging, I really shouldn’t be complaining about the lingering holdouts opposing the idea of living healthy and longer

When it comes to healthcare, WHO remains the global flagship in terms of setting priorities and adjusting policies in the ever-changing landscape of healthcare needs. In the past few years,

Today, we are going to have a look at a new study that shows that senescent, non-dividing aged cells can be rejuvenated using a new technique. Before we do that,

As I discussed in another article, rejuvenation biotechnology could potentially allow older adults to continue working and producing wealth for much longer than they can today, thus benefiting society in

The level of interest and support for rejuvenation biotechnology that targets age-related diseases is growing. Over the last few years, we have seen a significant increase in the number of

Today, we launch a new series on LEAF: the monthly roundup where we briefly discuss the latest news and articles about aging and rejuvenation from a number of different sources.

We have been talking about a number of new studies in past Journal Clubs, so we thought it was time to get into some aging theory. We chose to cover

Serge Faguet is a Russian entrepreneur, the owner of a profitable travel company, Ostrovok, and the founder of several tech startups, including a new secret, AI-related one in Silicon Valley.

The potential of the immune system to help repair tissue, including for peripheral nerve damage, Atherosclerosis, and Parkinson’s is considerable. Immune cells not only fight infection; as this new study shows,

Recently, we have explored the benefits that rejuvenation biotechnologies promise to bring to ourselves and the people close to us. I would imagine that most people have no difficulty acknowledging

We have been hard at work advocating, writing and supporting the development of life extension technologies, or as we call them, rejuvenation biotechnologies. During the course of our activities, we

There has been an increase in the level of interest in the field of rejuvenation biotechnology over the last few years. The recent entry of senolytic therapies that clear senescent

As I wrote in a different article, rejuvenation biotechnology promises a range of benefits for individuals. Lest anyone thinks that’s all rejuvenation has to offer, I reckon it’s worth discussing

I’m sure you’ve noticed that LEAF has been shouting from the rooftops for quite a while that rejuvenation biotechnologies need to happen, and we’re doing our best to make them

November has been a busy month in the world of rejuvenation biotechnology and life extension, as there has been both really good news and some rather bad news. Let’s have a look together, starting with the bad news and then moving on to decidedly more uplifting

With the recent increase of enthusiastic support for the idea of defeating aging, I really shouldn’t be complaining about the lingering holdouts opposing the idea of living healthy and longer lives for whatever reason. Nonetheless, I feel compelled to point out the jarring contradiction of a

When it comes to healthcare, WHO remains the global flagship in terms of setting priorities and adjusting policies in the ever-changing landscape of healthcare needs. In the past few years, WHO has been making steps towards preparing our society to handle the “silver tsunami” and the

Today, we are going to have a look at a new study that shows that senescent, non-dividing aged cells can be rejuvenated using a new technique. Before we do that, let’s take a look at what senescent cells are and how cellular senescence protects us from

As I discussed in another article, rejuvenation biotechnology could potentially allow older adults to continue working and producing wealth for much longer than they can today, thus benefiting society in many ways. However, some people are concerned that this might do more harm than good; imagine

The level of interest and support for rejuvenation biotechnology that targets age-related diseases is growing. Over the last few years, we have seen a significant increase in the number of popular science articles, news stories and research papers focusing on the idea that the aging processes

Today, we launch a new series on LEAF: the monthly roundup where we briefly discuss the latest news and articles about aging and rejuvenation from a number of different sources. We hope these roundups will be a great way to keep our readers in the loop.

We have been talking about a number of new studies in past Journal Clubs, so we thought it was time to get into some aging theory. We chose to cover one of the most cited and highly regarded damage theories of aging in this edition of

Serge Faguet is a Russian entrepreneur, the owner of a profitable travel company, Ostrovok, and the founder of several tech startups, including a new secret, AI-related one in Silicon Valley. For the last few weeks, his name has been all over the internet because of the

The potential of the immune system to help repair tissue, including for peripheral nerve damage, Atherosclerosis, and Parkinson’s is considerable. Immune cells not only fight infection; as this new study shows, they also help the nervous system remove debris, paving the way for nerve regeneration following injury.

Recently, we have explored the benefits that rejuvenation biotechnologies promise to bring to ourselves and the people close to us. I would imagine that most people have no difficulty acknowledging these benefits, but even so, many people tend to focus on potential large-scale downsides of rejuvenation

We have been hard at work advocating, writing and supporting the development of life extension technologies, or as we call them, rejuvenation biotechnologies. During the course of our activities, we have found that many people new to the topic have lots of questions and are naturally

There has been an increase in the level of interest in the field of rejuvenation biotechnology over the last few years. The recent entry of senolytic therapies that clear senescent cells from the body into human clinical trials have spurred even more interest in the field

As I wrote in a different article, rejuvenation biotechnology promises a range of benefits for individuals. Lest anyone thinks that’s all rejuvenation has to offer, I reckon it’s worth discussing other ways that this technology would benefit larger groups of people—namely, your friends and family. If

I’m sure you’ve noticed that LEAF has been shouting from the rooftops for quite a while that rejuvenation biotechnologies need to happen, and we’re doing our best to make them happen as soon as possible. The job isn’t easy; the fact that numerous people still raise